As of today (2024-05-16), the Trailing Annual Dividend Yield of Armata Pharmaceuticals is 0.00%.
The historical rank and industry rank for Armata Pharmaceuticals's Dividend Yield % or its related term are showing as below:
ARMP's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.37 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Armata Pharmaceuticals Dividend Yield % Historical Data
The historical data trend for Armata Pharmaceuticals's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Armata Pharmaceuticals's Dividend Yield %
For the Biotechnology subindustry, Armata Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Armata Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Armata Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Armata Pharmaceuticals's Dividend Yield % falls into.
Armata Pharmaceuticals Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Armata Pharmaceuticals (AMEX:ARMP) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Armata Pharmaceuticals Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Armata Pharmaceuticals's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Armata Pharmaceuticals (Armata Pharmaceuticals) Business Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Further, the company is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARMP has been successfully added to your 